Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2021 September;63(3) > Panminerva Medica 2021 September;63(3):402-3

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Panminerva Medica 2021 September;63(3):402-3

DOI: 10.23736/S0031-0808.19.03761-3

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Rosuvastatin reduces expression of tissue factor through inhibiting RhoA/ROCK pathway to ameliorate atherosclerosis

Jingwei ZHOU 1, Guangjie YIN 2, Tao YU 3, Yubao ZHANG 1, Xintao TIAN 1, Di XIA 1, Lei SHI 1

1 Department of Emergency Internal Medicine, Affiliated Hospital of Qingdao University, Qingdao, China; 2 Department of Gynecology, Affiliated Hospital of Qingdao University, Qingdao, China; 3 Department of Laoshan Community Health Service Center General Clinic, Laoshan, China



top of page